Building a peptide therapy program in your practice

A peptide therapy program lives or dies on operations, not marketing. Patients and regulators alike are reassured by the same thing: a program that is sourced, documented, and run like clinical infrastructure. Here is the backbone.

1. Source from a licensed pharmacy

Start with a state-licensed 503A pharmacy partner that compounds under valid prescriptions and provides a Certificate of Analysis on every lot. This single decision determines how defensible everything downstream is. Avoid “research use only” material for patient care entirely.

2. Get your credentialing in order

Confirm your professional license and NPI, and expect your supplier to verify them. Maintain prescriber oversight for every preparation dispensed. Credentialing is not bureaucracy — it is what separates a clinical program from a gray-market operation.

3. Handle product like the clinical material it is

Store refrigerated at 2–8°C, protect from light, and follow reconstitution and beyond-use dating exactly. Keep a calibrated thermometer in your storage fridge and inspect every shipment on arrival. Potency you paid for is lost in poor handling.

4. Keep patient communication accurate

Many peptides are not FDA-approved and have a limited human evidence base. Patient-facing language should be measured, avoid efficacy guarantees, and reflect the actual regulatory status of each product. Accurate communication protects both the patient and the practice.

Where we fit

We supply the first link in that chain — pharmacy-backed, COA-documented, cold-chain-shipped product for licensed practices — so your program starts on solid ground.

This article is general educational information for licensed practitioners and is not medical, legal, or regulatory advice. Compounded preparations are not FDA-approved; availability and permitted use depend on current FDA and state regulations, which change. Confirm requirements for your jurisdiction with qualified counsel and your pharmacy partner.